Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hengagliflozin proline for weight management in obese adults
ChiCTR2300074046Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity comparing Hengagliflozin proline + diet-exercise with Placebo + diet-exercise (2 arms). Primary endpoint: Proportion of patients with ≥5% weight loss at week 12. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
hengagliflozin proline
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2300074046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074046.